CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 192 filers reported holding CYTOKINETICS INC in Q2 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $823,598 | +20.7% | 27,957 | +33.7% | 0.00% | – |
| Q2 2023 | $682,198 | -9.2% | 20,914 | -2.0% | 0.00% | – |
| Q1 2023 | $751,078 | -22.9% | 21,344 | +0.3% | 0.00% | -100.0% |
| Q4 2022 | $974,683 | -15.0% | 21,272 | -10.1% | 0.00% | 0.0% |
| Q3 2022 | $1,147,000 | +21.5% | 23,671 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $944,000 | +29.3% | 24,036 | +21.2% | 0.00% | – |
| Q1 2022 | $730,000 | -13.0% | 19,834 | +7.7% | 0.00% | – |
| Q4 2021 | $839,000 | +49.0% | 18,415 | +16.8% | 0.00% | – |
| Q3 2021 | $563,000 | +39.0% | 15,765 | -23.0% | 0.00% | – |
| Q2 2021 | $405,000 | -7.3% | 20,477 | +8.9% | 0.00% | – |
| Q1 2021 | $437,000 | +76.9% | 18,797 | +58.0% | 0.00% | – |
| Q4 2020 | $247,000 | -16.3% | 11,897 | -12.8% | 0.00% | – |
| Q3 2020 | $295,000 | -1.7% | 13,639 | +7.0% | 0.00% | – |
| Q2 2020 | $300,000 | +26.6% | 12,745 | -36.6% | 0.00% | – |
| Q1 2020 | $237,000 | – | 20,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,106,989 | $14,159,000 | 2.50% |
| Healthcare Value Capital, LLC | 100,000 | $672,000 | 0.71% |
| First Light Asset Management, LLC | 218,792 | $1,470,000 | 0.69% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 435,202 | $2,925,000 | 0.67% |
| TFS CAPITAL LLC | 899,951 | $6,048,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,250 | $2,838,000 | 0.28% |
| ALGERT GLOBAL LLC | 73,181 | $492,000 | 0.27% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $15,603,000 | 0.13% |
| Leisure Capital Management | 17,567 | $118,000 | 0.12% |
| Rotella Capital Management, Inc. | 15,778 | $106,000 | 0.09% |